Back
Anheuser-Busch InBev SA/NV Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
58
BUDFF
Anheuser-Busch InBev SA/NV
Last Price:
63.97
Seasonality Move:
1.59%
Buy
73
RYTM
Rhythm Pharmaceuticals
Last Price:
54.42
Seasonality Move:
11.04%
Buy
58
Anheuser-Busch InBev SA/NV (BUDFF)
is a Buy
Is Anheuser-Busch InBev SA/NV a Buy, Sell or Hold?
- The current Anheuser-Busch InBev SA/NV [BUDFF] share price is $63.97. The Score for BUDFF is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BUDFF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
73
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
- The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
- RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BUDFF Stock Price Chart
What is Anheuser-Busch InBev SA/NV's stock price today?
-
The Anheuser-Busch InBev SA/NV share price today is $63.97
The current trend is moderately bullish and BUDFF is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $53.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.
BUDFF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.01 | Buy |
Relative Strength Index (14 RSI): | 59.46 | Buy |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (60.44 - 63.96) | Buy |
Bollinger Bands (100): | (59.25 - 63.71) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.46 | Buy |
Relative Strength Index (14 RSI): | 67.83 | Buy |
Chaikin Money Flow: | -159819 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.64 - 50.28) | Buy |
Bollinger Bands (100): | (39.46 - 48.56) | Buy |
BUDFF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.31 | Sell |
20-day SMA: | 62.68 | Buy |
50-day SMA: | 61.31 | Buy |
200-day SMA: | 61.67 | Buy |
8-day EMA: | 64.02 | Sell |
20-day EMA: | 63.02 | Buy |
50-day EMA: | 61.88 | Buy |
200-day EMA: | 60.93 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 50.55 | Buy |
20-day SMA: | 48.38 | Buy |
50-day SMA: | 47.86 | Buy |
200-day SMA: | 43.39 | Buy |
8-day EMA: | 50.8 | Buy |
20-day EMA: | 49.06 | Buy |
50-day EMA: | 47.17 | Buy |
200-day EMA: | 41.51 | Buy |
Anheuser-Busch InBev SA/NV Earnings Growth & BUDFF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.
Anheuser-Busch InBev SA/NV Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |